291 related articles for article (PubMed ID: 23673020)
1. Pancreatic cancer genomics: insights and opportunities for clinical translation.
Makohon-Moore A; Brosnan JA; Iacobuzio-Donahue CA
Genome Med; 2013; 5(3):26. PubMed ID: 23673020
[TBL] [Abstract][Full Text] [Related]
2. Genomic alterations in pancreatic cancer and their relevance to therapy.
Takai E; Yachida S
World J Gastrointest Oncol; 2015 Oct; 7(10):250-8. PubMed ID: 26483879
[TBL] [Abstract][Full Text] [Related]
3. Pathology of incipient pancreatic cancer.
Hruban RH; Wilentz RE; Goggins M; Offerhaus GJ; Yeo CJ; Kern SE
Ann Oncol; 1999; 10 Suppl 4():9-11. PubMed ID: 10436775
[TBL] [Abstract][Full Text] [Related]
4. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.
Fischer CG; Wood LD
J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857
[TBL] [Abstract][Full Text] [Related]
5. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
6. Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic.
Du Y; Zhao B; Liu Z; Ren X; Zhao W; Li Z; You L; Zhao Y
J Cancer; 2017; 8(4):513-522. PubMed ID: 28367231
[TBL] [Abstract][Full Text] [Related]
7. Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).
Koorstra JB; Feldmann G; Habbe N; Maitra A
Langenbecks Arch Surg; 2008 Jul; 393(4):561-70. PubMed ID: 18283486
[TBL] [Abstract][Full Text] [Related]
8. Genetic progression of pancreatic cancer.
Cowan RW; Maitra A
Cancer J; 2014; 20(1):80-4. PubMed ID: 24445769
[TBL] [Abstract][Full Text] [Related]
9. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.
van Heek NT; Meeker AK; Kern SE; Yeo CJ; Lillemoe KD; Cameron JL; Offerhaus GJ; Hicks JL; Wilentz RE; Goggins MG; De Marzo AM; Hruban RH; Maitra A
Am J Pathol; 2002 Nov; 161(5):1541-7. PubMed ID: 12414502
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic alterations in pancreatic carcinogenesis.
Delpu Y; Hanoun N; Lulka H; Sicard F; Selves J; Buscail L; Torrisani J; Cordelier P
Curr Genomics; 2011 Mar; 12(1):15-24. PubMed ID: 21886451
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men.
Ottenhof NA; Milne AN; Morsink FH; Drillenburg P; Ten Kate FJ; Maitra A; Offerhaus GJ
Arch Pathol Lab Med; 2009 Mar; 133(3):375-81. PubMed ID: 19260743
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer.
Zhang X; Mao T; Zhang B; Xu H; Cui J; Jiao F; Chen D; Wang Y; Hu J; Xia Q; Ge W; Li S; Yue M; Ma J; Yao J; Wang Y; Wang Y; Shentu D; Zhang X; Chen S; Bai Y; Wang Y; Zhang X; Liu Q; Sun Y; Fu D; Liu Y; Xiong L; Wang L
EBioMedicine; 2022 Mar; 77():103897. PubMed ID: 35231699
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias.
Lisovsky M; Dresser K; Woda B; Mino-Kenudson M
Hum Pathol; 2010 Jun; 41(6):902-9. PubMed ID: 20233622
[TBL] [Abstract][Full Text] [Related]
15. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
Padella A; Ghelli Luserna Di Rorà A; Marconi G; Ghetti M; Martinelli G; Simonetti G
J Hematol Oncol; 2022 Jan; 15(1):10. PubMed ID: 35065680
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic signaling pathways in pancreatic ductal adenocarcinoma.
Agrawal R; Natarajan KN
Adv Cancer Res; 2023; 159():251-283. PubMed ID: 37268398
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues.
Voutsadakis IA; Digklia A
Chin Clin Oncol; 2023 Feb; 12(1):2. PubMed ID: 36922358
[TBL] [Abstract][Full Text] [Related]
18. Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients.
Dalmasso B; Puccini A; Catalano F; Borea R; Iaia ML; Bruno W; Fornarini G; Sciallero S; Rebuzzi SE; Ghiorzo P
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563100
[TBL] [Abstract][Full Text] [Related]
19. The molecular genetics of pancreatic ductal carcinoma.
Sohn TA
Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.
Pelosi E; Castelli G; Testa U
Biomedicines; 2017 Nov; 5(4):. PubMed ID: 29156578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
